SCHEMBL9043154

SCHEMBL9043154

Cc1ccc(-c2c(Cl)ncnc2NS(=O)(=O)c2cc(C)ccc2C)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
GAA P10253 1/20 0.44
TSHR P16473 1/20 0.44
EDNRA P25101 3/20 0.43
EDNRB P24530 2/20 0.43
MAPT P10636 2/20 0.43
TP53 P04637 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 2/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
RXFP1 Q9HBX9 2/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
PKM P14618 1/20 0.41
BRD4 O60885 1/20 0.40
BRD2 P25440 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9493265 0.90 KMT2A (0.46) ALDH1A1GAAEDNRAMAPTSMN1; SMN2
SCHEMBL9047803 0.88 PKM (0.55) ALDH1A1EDNRAMAPTTP53LMNA
SCHEMBL9045052 0.83 MEN1 (0.55) ALDH1A1EDNRAEDNRBMAPTKMT2A
SCHEMBL9491423 0.80 EDNRA (0.43) ALDH1A1EDNRAEDNRBMAPTKMT2A
SCHEMBL9046709 0.80 ALDH1A1 (0.60) ALDH1A1EDNRAEDNRBMAPTKMT2A
SCHEMBL9052684 0.80 EDNRA (0.68) EDNRAEDNRB
SCHEMBL6785011 0.79 EDNRA (0.67) ALDH1A1EDNRAEDNRBMAPTLMNA
SCHEMBL9044020 0.78 EDNRA (0.42) ALDH1A1EDNRAEDNRBMAPTKMT2A
SCHEMBL7304221 0.78 ALDH1A1 (0.41) ALDH1A1GAATSHREDNRAEDNRB
SCHEMBL9044797 0.78 RXFP1 (0.54) LMNARXFP1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0510526-B1 Use of sulfonamides as drug and new sulfonamides HOFFMANN LA ROCHE (CH) 1996-12-04 EP disclosed
US-5270313-A Treatment of circulatory disorders HOFFMANN-LA ROCHE INC. (US) 1993-12-14 US disclosed
EP-0510526-A1 Use of sulfonamides as drug and new sulfonamides F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1992-10-28 EP disclosed